BusinessUpdated 17 min ago
Blackstone puts up $1.5 billion for Pfizer obesity drug studies
Pfizer is seeking to challenge market leaders Eli Lilly & Co. and Novo Nordisk A/S in the weight-loss market after acquiring Metsera Inc. for up to $10 billion last year
Continue reading on BusinessLine
Read full story Hello Headlines links you to the original publisher for the full story.

